23 March 2009 - The Centre for Proteomic and Genomic Research (CPGR) and Simugen have joined forces to advance toxicity testing of novel drug applications.
The agreement involves the development of novel biomarker assays for the prediction of toxicity of existing and novel drug compounds.
